(Press-News.org) LOS ANGELES (Feb. 14, 2013) – New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
"Excessive uterine bleeding is a common problem we see in gynecological practices and emergency rooms. It can interfere with women's daily activities and put them at risk for anemia and other more serious health consequences caused by blood loss," said Anita L. Nelson, MD, a LA BioMed lead investigator and corresponding author of the study. "Until now, there has been no Food and Drug Administration-approved products for short-term treatment of this condition. Based on our study, we conclude that this new progestogen-only treatment is effective in stopping acute abnormal uterine bleeding."
Within five days of receiving the therapy, bleeding had ceased in 44 of the 48 women in the study, and the other four were only experiencing spotting. The mean time to bleeding cessation was 2.6 days, leading the researchers to conclude the progestogen-only treatment was an effective short-term therapy for acute abnormal uterine bleeding.
In the pilot study, the patients received a 150-milligram injection of Depomedroxyprogesterone acetate (DMPA) and then were given medroxyprogesterone acetate (MPA) 20 milligram pills that were to be taken orally every eight hours for three days.
"This is the largest prospective study to date to measure the effectiveness of a proposed hormonal treatment for excessive uterine bleeding," said Dr. Nelson. "The women in the study experienced excellent success with this relatively low dose progestogen-only therapy. This therapy also has the potential for offering longer-term protection than prior therapies."
The therapy was shown to halt bleeding rapidly while appropriate testing could identify the underlying causes of the excessive bleeding. As such, Dr. Nelson said the therapy provides a "temporary bridge to long-term targeted therapies." She also said the regimen had "good compliance, few side effects and high patient satisfaction." In addition, she said it was an attractive treatment option for women with contraindications to estrogen, those who need more prolonged therapy and those who may have difficulty with daily pill administration.
### About LA BioMed
Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.
New LA BioMed research identifies effective treatment for common gynecological problem
Study findings could help women suffering from excessive uterine bleeding
2013-02-14
ELSE PRESS RELEASES FROM THIS DATE:
Love of musical harmony is not nature but nurture
2013-02-14
Our love of music and appreciation of musical harmony is learnt and not based on natural ability – a new study by University of Melbourne researchers has found.
Associate Professor Neil McLachlan from the Melbourne School of Psychological Sciences said previous theories about how we appreciate music were based on the physical properties of sound, the ear itself and an innate ability to hear harmony.
"Our study shows that musical harmony can be learnt and it is a matter of training the brain to hear the sounds," Associate Professor McLachlan said.
"So if you thought ...
Dogs spot the dog
2013-02-14
Dogs pick out faces of other dogs, irrespective of breeds, among human and other domestic and wild animal faces and can group them into a category of their own. They do that using visual cues alone, according to new research by Dr. Dominique Autier-Dérian from the LEEC and National Veterinary School in Lyon in France and colleagues. Their work, the first to test dogs' ability to discriminate between species and form a "dog" category in spite of the huge variability within the dog species, is published online in Springer's journal Animal Cognition.
Individuals from the ...
Combining quantum information communication and storage
2013-02-14
Aalto University researchers in Finland have successfully connected a superconducting quantum bit, or qubit, with a micrometer-sized drum head. Thus they transferred information from the qubit to the resonator and back again.
- This work represents the first step towards creating exotic mechanical quantum states. For example, the transfer makes it possible to create a state in which the resonator simultaneously vibrates and doesn't vibrate, says professor Mika Sillanpää from Aalto University, who runs the research group.
A qubit is the quantum-mechanical equivalent ...
Gut microbes could determine the severity of melamine-induced kidney disease
2013-02-14
Microbes present in the gut can affect the severity of kidney disease brought on by melamine poisoning, according to an international study led by Professor Wei Jia at the University of North Carolina in collaboration with the research group of Professor Jeremy Nicholson at Imperial College London.
In 2008, nearly 300,000 Chinese children were hospitalised with kidney disease brought on by supplies of powdered milk deliberately contaminated with melamine to boost the apparent protein content. Although melamine was known to combine with uric acid in the children's bodies ...
What green algae are up to in the dark
2013-02-14
How green algae produce hydrogen in the dark is reported by biologists at the Ruhr-Universität Bochum in the "Journal of Biological Chemistry". Hereby, they have uncovered a mechanism for the production of the gas which has hardly been examined before; usually, researchers are interested in light-driven hydrogen synthesis. "Hydrogen could help us out of the energy crisis", says Prof. Dr. Thomas Happe, head of the working group Photobiotechnology. "If you want to make green algae produce more hydrogen, it is important to understand all the production pathways."
Green algae ...
Life experiences put their stamp on the next generation: New insights from epigenetics
2013-02-14
Philadelphia, PA, February 14, 2013 – The 18th century natural philosopher Jean-Baptiste Lamarck proposed that the necks of giraffes lengthened as a consequence of the cumulative effort, across generations, to reach leaves just out of their grasp. This view of evolution was largely abandoned with the advent of modern genetic theories to explain the transmission of most important traits and many medical illnesses across generations.
However, there has long been the impression that major life events, like psychological traumas, not only have effects on individuals who directly ...
Physical activity linked to lower rates of depression in bariatric surgery patients
2013-02-14
PITTSBURGH, Feb. 14, 2013 – Adults undergoing bariatric surgery who are more physically active are less likely to have depressive symptoms and to have recently received medication or counseling for depression or anxiety than their less active counterparts, according to new research led by the University of Pittsburgh Graduate School of Public Health.
"Typically, clinical professionals manage their patients' depression and anxiety with counseling and/or antidepressant or anti-anxiety medication," said Wendy C. King, Ph.D., epidemiologist at Pitt Public Health and lead ...
Risk of leukemia after cancer chemotherapy persists
2013-02-14
(WASHINGTON)- While advancements in cancer treatment over the last several decades have improved patient survival rates for certain cancers, some patients remain at risk of developing treatment-related leukemia, according to results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH).
Chemotherapy is often a highly effective treatment for cancer, but certain drugs have also been shown in a range of studies to increase a patient's risk of developing therapy-related acute myeloid leukemia (tAML), a rare but frequently fatal ...
Scientists identify new therapeutic target for coronary heart disease
2013-02-14
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
They have discovered that an enzyme known as ADAMTS7 plays a crucial role in the build-up of cells in the coronary arteries which lead to coronary heart disease.
Coronary heart disease (also known as coronary artery disease) is the nation's biggest killer, with around 94,000 deaths in the UK each year*. The condition happens when the blood ...
Scientists find calcium is the initial trigger in our immune response to healing
2013-02-14
For the first time scientists studying the cellular processes underlying the body's response to healing have revealed how a flash of calcium is the very first step in repairing damaged tissue. The findings, published in Current Biology, could lead to new therapies that speed up the healing process following injury or surgery.
Until recently, very little was known about how damaged tissue activates and attracts the first white blood cells to the wound — the first stage in the healing process. However, researchers from the University of Bristol's School of Biochemistry ...
LAST 30 PRESS RELEASES:
Mitochondrial encephalopathy caused by a new biallelic repeat expansion
Nanoplastics can impair the effect of antibiotics
Be humble: Pitt studies reveal how to increase perceived trustworthiness of scientists
Promising daily tablet increases growth in children with dwarfism
How 70% of the Mediterranean Sea was lost 5.5 million years ago
Keeping the lights on and the pantry stocked: Ensuring water for energy and food production
Parkinson’s Paradox: When more dopamine means more tremor
Study identifies strategy for AI cost-efficiency in health care settings
NIH-developed AI algorithm successfully matches potential volunteers to clinical trials release
Greg Liu is in his element using chemistry to tackle the plastics problem
Cocoa or green tea could protect you from the negative effects of fatty foods during mental stress - study
A new model to explore the epidermal renewal
Study reveals significant global disparities in cancer care across different countries
Proactively screening diabetics for heart disease does not improve long-term mortality rates or reduce future cardiac events, new study finds
New model can help understand coexistence in nature
National Poll: Some parents need support managing children's anger
Political shadows cast by the Antarctic curtain
Scientists lead study on ‘spray on, wash off’ bandages for painful EB condition
A new discovery about pain signalling may contribute to better treatment of chronic pain
Migrating birds have stowaway passengers: invasive ticks could spread novel diseases around the world
Diabetes drug shows promise in protecting kidneys
Updated model reduces liver transplant disparities for women
Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller
‘Teen-friendly’ mindfulness therapy aims to help combat depression among teenagers
Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds
Kidney outcomes in transthyretin amyloid cardiomyopathy
Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting
Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction
Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction
Hormone therapy reshapes the skeleton in transgender individuals who previously blocked puberty
[Press-News.org] New LA BioMed research identifies effective treatment for common gynecological problemStudy findings could help women suffering from excessive uterine bleeding